Journal of Renal Nutrition
Volume 15, Issue 1 , Pages 121-124 , January 2005

The impact of inflammation on metabolic regulation in chronic kidney disease: A review

  • Gianfranco Guarnieri, MD

      Affiliations

    • Department of Clinical, Morphological, and Technological Sciences, Division of Internal Medicine, University of Trieste, Trieste,Italy.
    • Corresponding Author InformationAddress reprint requests to Gianfranco Guarnieri, MD, Clinica Medica, Ospedale Cattinara, Strada di Fiume 447, 34100 Trieste, Italy.
    • ,
  • Gabriele Grassi, MD, PhD

      Affiliations

    • Department of Clinical, Morphological, and Technological Sciences, Division of Internal Medicine, University of Trieste, Trieste,Italy.
    • ,
  • Rocco Barazzoni, MD, PhD

      Affiliations

    • Department of Clinical, Morphological, and Technological Sciences, Division of Internal Medicine, University of Trieste, Trieste,Italy.
    • ,
  • Michela Zanetti, MD, PhD

      Affiliations

    • Department of Clinical, Morphological, and Technological Sciences, Division of Internal Medicine, University of Trieste, Trieste,Italy.
    • ,
  • Gianni Biolo, MD, PhD

      Affiliations

    • Department of Clinical, Morphological, and Technological Sciences, Division of Internal Medicine, University of Trieste, Trieste,Italy.

References 

  1. Choy EHS , Panayi GS . Cytokine pathways and joint inflammation in rheumathoid arthritis . N Engl J Med . 2001;344:907–916
  2. Hotchkiss RS , Karl IE . The pathophysiology and treatment of sepsis . N Engl J Med . 2003;348:138–150
  3. Girndt M , Sester U , Sester M , et al.   The interleukin-10 promoter genotype determines clinical immune function in hemodialysis patients . Kidney Int . 2001;60:2385–2391
  4. Heeschen C , Dimmeler S , Hamm CW , et al.   Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes . Circulation . 2003;107:2109–2114
  5. Guarnieri G , Antonione R , Biolo G . Mechanisms of malnutrition in uremia . J Ren Nutr . 2003;13:153–157
  6. Perianayagam MC , Jaber BL , Guo D , et al.   Defective interleukin-10 synthesis by peripheral blood mononuclear cells among hemodialysis patients . Blood Purif . 2002;20:543–550
  7. Guarnieri G , Toigo G , Fiotti N , et al.   Mechanisms of malnutrition in uremia . Kidney Int . 1997;62(suppl):S41–S44
  8. Freemont AJ . The pathology of dialysis . Semin Dial . 2002;15:227–231
  9. Kalousova M , Zima T , Tesar V , et al.   Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis patients . Kidney Int . 2003;84(suppl):S62–S64
  10. Mezzano D , Pais EO , Aranda E , et al.   Inflammation, not hyperhomocystinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia . Kidney Int . 2001;60:1844–1850
  11. Paniagua R , Frias Y , de Ventura MJ , et al.   C-reactive protein and anti-Chlamydia pneumoniae antibodies as risk factors of cardiovascular death in incident patients on peritoneal dialysis . Perit Dial Int . 2003;23:132–137
  12. Kaysen GA , Dubin JA , Muller HG , et al.  The HEMO Study Group   The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients . Kidney Int . 2000;58:346–352
  13. Haukim N , Bidwell JL , Smith AJ , et al.   Cytokine gene polymorphism in human disease (on-line databases) . Genes Immun . 2002;3:313–330
  14. Bosutti A , Barazzoni R , Savoldi S , et al.   Interleukin-10 genotype and gene expression affect the severity of inflammatory state in haemodialysis patients . S1, abstr Clin Nutr . 2003;22:S39
  15. Girnd M , Kaul H , Sester U , et al.   Anti-inflammatory interleukin-10 geneotype protects dialysis patients from cardiovascular events . Kidney Int . 2002;62:949–955
  16. Klasing KC . Nutritional aspects of leukocytic cytokines . J Nutr . 1988;118:1436–1446
  17. de Alvaro C , Teruel T , Hernandez R , et al.   Tumor necrosis factor α produces insulin resistance in skeletal muscle by activation of inhibitor κB kinase in a p38 MAPK-dependent manner . J Biol Chem . 2004;279:17070–17078
  18. Li YP , Lecker SH , Chen Y , et al.   TNF-α increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k . FASEB J . 2003;17:1048–1057
  19. Nguyen LT , Bedu M , Caillaud D , et al.   Increased resting energy expenditure is related to plasma TNF-α concentration in stable COPD patients . Clin Nutr . 1999;18:269–274
  20. Guarnieri G, Bosutti A, Biolo G: Treatment of inflammation in chronically uremic patients. Semin Nephrol 2004, in press
  21. Chang JW , Yang WS , Min WK , et al.   Effects of simvastatin on high sensitivity C-reactive protein and serum albumin in hemodialysis patients . Am J Kidney Dis . 2002;39:1213–1217
  22. Kranzhofer R , Browatzki M , Schmidt J , et al.   Angiotensin II activates the proinflammatory transcription factor nuclear factor-κB in human monocytes . Biochem Biophys Res Commun . 1999;257:826–828
  23. Navalkar S , Parthasarathy S , Santanam N , et al.   Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis . J Am Coll Cardiol . 2001;37:440–444
  24. Stenvinkel P , Andersson P , Wang T , et al.   Do ACE-inhibitors suppress tumour necrosis factor-α production in advanced chronic renal failure? . J Intern Med . 1999;246:503–507
  25. Breuillé D , Farge MC , Rosé F , et al.   Pentoxifylline decreases body weight loss and muscle protein wasting characteristics of sepsis . Am J Physiol . 1993;265:E660–E666
  26. Biolo G , Ciocchi B , Bosutti A , et al.   Pentoxifylline acutely reduces protein catabolism in chronically uremic patients . Am J Kidney Dis . 2002;40:1162–1172
  27. Gullestad L , Semb AG , Holt E , et al.   Effect of thalidomide in patients with chronic heart failure . Am Heart J . 2002;144:847–850
  28. Cappelli P , Di Liberato L , Stuard S , et al.   N-3 polyunsaturated fatty acid supplementation in chronic progressive renal disease . J Nephrol . 1997;10:157–162
  29. Zhong Z , Wheeler MD , Li X , et al.   L-Glycine (A novel antiinflammatory, immunomodulatory, and cytoprotective agent) . Curr Opin Clin Nutr Metab Care . 2003;6:229–240
  30. Guarnieri G , Situlin R , Biolo G . Carnitine metabolism in uremia . Am J Kidney Dis . 2001;38(suppl):S63–S67
  31. Hurot JM , Cucherat M , Haugh M , et al.   Effects of L-carnitine supplementation in maintenance hemodialysis patients (A systematic review) . J Am Soc Nephrol . 2002;13:708–714
  32. Vesela E , Racek J , Trefil L , et al.   Effect of L-carnitine supplementation in hemodialysis patients . Nephron . 2001;88:218–223
  33. Winter BK , Fiskum G , Gallo LL . Effects of L-carnitine on serum triglyceride and cytokine levels in rat models of cachexia and septic shock . Br J Cancer . 1995;72:1173–1179
  34. Jirillo E , Altamura M , Munno I , et al.   Effects of acetyl-L-carnitine oral administration on lymphocyte antibacterial activity and TNF-α levels in patients with active pulmonary tuberculosis. A randomized double blind versus placebo study . Immunopharmacol Immunotoxicol . 1991;13:135–146
  35. Greiwe JS , Cheng B , Rubin DC , et al.   Resistance exercise decreases skeletal muscle tumor necrosis factor α in frail elderly humans . FASEB J . 2001;15:475–482

PII: S1051-2276(04)00173-6

doi: 10.1053/j.jrn.2004.09.016

Journal of Renal Nutrition
Volume 15, Issue 1 , Pages 121-124 , January 2005

Article Tools

* Image Usage & Resolution